# Accurate International

**Canonical:** https://apis.io/providers/accurateinternational/  
**Website:** https://en.bio-accurate.com/  
**APIs profiled:** 0

Accurate International Biotechnology (trading as ACCURATE, 广州创芯国际生物科技有限公司) is a Guangzhou, China biotechnology company founded in 2018 that builds the full industry chain around organoid technology for cancer precision medicine, new drug research and regenerative medicine. Its products are wet-lab reagents, instruments and consumables rather than software: Accuroid organoid culture media, the AccuArray microarray organoid chip, the AOMF microfluidic organoid chip and 3D bioprinter, the AccuLumi high-throughput chemiluminescence detector, and Accuauto automated organoid culture workstations. On top of those it sells services — BUDcare and BUDhealth patient-derived tumor organoid drug-sensitivity testing delivered through Guangzhou Chuangxin Independent Clinical Laboratory, and organoid-model new-drug R&D services for pharma — and reports 32,000+ organoid cultures, 5,000+ tumor organoid models, 200+ clinical collaborators and 100+ filed patents. It holds subsidiaries in Beijing, Shanghai and Macau plus a European entity, and has raised Pre-A (2020), Series A (2021), a 100M RMB Pre-B (2022) and a Series B (2024). ACCURATE describes internal digital assets — the AOD Tronchip organoid database launched in 2023 and a cancer "deep-thinking" AI model built in 2024 — but publishes no developer portal, API reference, SDK, CLI, status page or public GitHub organization, and no OpenAPI, AsyncAPI, GraphQL, MCP or A2A agent-card surface was found on any host it operates.

## Kin Score — 4.5 / 100 (minimal)

Scored 2026-09-06 under rubric 0.19.0.

| Facet | Score |
|---|---|
| Discoverability | 57.4 |
| Contract Quality | 0.0 |
| Governance | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 2.4 |
| Commercial Clarity | 0.0 |
| Access Clarity | 0.0 |

Regulatory layer — **Health**: 7.5 (matched via tags).

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |
| Delegated Identity | no |
| Protected Resource Metadata | no |
| Dynamic Client Registration | no |
| Agentic Commerce | no |

## Security (1)

- **Accurateinternational Domain Security** — TLSv1.3 · HSTS

## Tags

Company, Biotechnology, Life Sciences, Precision Medicine, Oncology, Organoids, Laboratory Instruments, Clinical Diagnostics, Drug Discovery, China

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/accurateinternational/). Scores are computed from the provider's own public artifacts under a published rubric.